Dementia: Scientists Find Specific Brain Regions Damaged by High Blood Pressure

Health & Lifestyle
194

Translate to Spanish or other 102 languages!

More than 55 million people globallyTrusted Source have dementia — an umbrella term for a number of diseases causing memory loss and cognitive declineTrusted Source. Image for illustration purposes
More than 55 million people globallyTrusted Source have dementia — an umbrella term for a number of diseases causing memory loss and cognitive declineTrusted Source. Image for illustration purposes

Medical News Today

- Advertisement -
  • High blood pressure is a known risk factor for developing dementia. 
  • Researchers recently identified the specific areas of the brain that may be damaged by high blood pressure and are linked to the development of dementia. 
  • Further studies may help researchers identify patients at high risk of cognitive impairment. 

More than 55 million people globallyTrusted Source have dementia — an umbrella term for a number of diseases causing memory loss and cognitive declineTrusted Source.

Follow the link below to Medical News Today to read the full Story:

https://www.medicalnewstoday.com/articles/dementia-scientists-find-specific-brain-regions-damaged-by-high-blood-pressure

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
FDA Approves First Over-the-Counter Naloxone Nasal Spray
Next article
Preventing Traumatic Brain Injury

More Articles

FDA Authorizes First Wearable Device that Continuously Monitors Both Ketone Levels and Blood Sugar

The U.S. Food and Drug Administration today authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for people aged 2 years and older living with diabetes.

Golden Years, Restless Nights: How Aging Transforms Your Sleep Cycles

If you have trouble falling asleep or staying asleep, your age could be playing a role.

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

The U.S. Food and Drug Administration approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced pancreatic cancer months ahead of schedule. 

STHS Behavioral’s Webinar on Suicide Prevention Awareness, Sept. 3rd

More than 49,000 people died by suicide in the United States in 2023, according to the Centers for Disease Control and Prevention (CDC), making it one of the leading causes of death among adolescents and adults.
- Advertisement -